Risk factors and clinical outcomes of infectious events in the first 24 months after kidney transplant in a large retrospective cohort Maria Mazzitelli, Marianna Alessi, Federico Ferretti, Giacomo Berti, Federico Nalesso, Marianna Di Bello, Lucia Federica Stefanelli, Caterina Di Bella, Lolita Sasset, Francesco Tuci, Vincenzo Scaglione, Lucrezia Furian, Annamaria Cattelan International Journal of Infectious Diseases, 2026 OBJECTIVES: Kidney transplant recipients remain highly vulnerable to infectious complications, particularly in the early post-transplant period, with potential effects on hospitalization, graft outcomes, and survival. We aimed to quantify the incidence, timing, microbiology, predictors, and clinical impact of infections occurring within 24 months after kidney transplantation in a large contemporary single-center cohort. METHODS: We retrospectively analyzed 784 adult kidney transplant recipients transplanted between 2013 and 2023 at Padua University Hospital. Infectious events were defined using microbiological documentation and standardized clinical criteria; cumulative incidence was modeled with Fine-Gray competing risk regression (graft loss and death as competing events). Predictors of 2-year mortality were explored using Cox regression. RESULTS: Overall, 486 recipients (62.0%) experienced at least one infectious event, and 253 (32.3%) had multiple episodes. Bacterial infections were most frequent (43.2%), dominated by urinary tract infections (33.2% overall), followed by viral infections (28.6%; mainly cytomegalovirus reactivation [16.5%] and BK polyomavirus [8.8%]) and fungal infections (3.2%), largely because of Candida spp. Median time to first infection was early (approximately 2 months), and infections were associated with substantial hospitalization burden. In multivariable competing risk models, female sex (sub-distribution hazard ratio [sHR] 1.50, 95% confidence interval [CI] 1.25-1.80), multimorbidity (sHR = 1.25, 95% CI 1.01-1.55) and mycophenolate immunosuppressive combination (sHR 1.41, 95% CI 1.10-1.80) independently predicted any infection. Living-donor transplantation was independently associated with viral infections (sHR 1.42, P = 0.034). Two-year mortality was low (2.9%) and was mainly associated with infection (HR: 4.17, 95% CI: 1.23-14.29; P = 0.021). CONCLUSION: Infections remain highly prevalent within 24 months after kidney transplantation; risk-adapted prevention and tailored immunosuppression strategies should prioritize recipients at increased risk, particularly women, combined-transplant recipients, and those with high comorbidity burden.
Predictors of mortality of Enterococcus faecium bloodstream infections: results from a 5-year retrospective study at Padua University Hospital Maria Mazzitelli, Alberto Enrico Maraolo, Umberto Barbieri, Vincenzo Scaglione, Federico Giovagnorio, Lolita Sasset, Sara Lo Menzo, Alberto Ferrarese, Ignazio Castagliuolo, Patrizia Burra, Lucrezia Furian, Umberto Cillo, Federico Nalesso, Paolo Navalesi, Ivo Tiberio, Paolo Simioni, Annamaria Cattelan International Journal of Infectious Diseases, 2026 OBJECTIVES: Enterococcus faecium (EF) bloodstream infections (BSIs) cause significant morbidity and mortality in health care settings. We herein report a cohort of EF BSIs with the aim of identifying predictors of 30-day in-hospital mortality. METHODS: This was a retrospective cohort study including hospitalized patients with EF BSIs from 2019 to 2023. We collected data on demographic characteristics, clinical and microbiological variables, laboratory findings, treatments, and deaths. Cox proportional hazards models were used to estimate hazard ratios with 95% confidence intervals for 30-day in-hospital mortality, to quantify the prognostic significance of risk factors after multivariable adjustment. A backward variable selection process was implemented in the Cox regression model to identify risk factors significantly associated with mortality. RESULTS: A total of 604 patients were included. The overall 30-day in-hospital mortality rate was 25.8%. Significant predictors of mortality included the presence of septic shock, Pitt bacteremia score values ≥2, and liver cirrhosis, while early source control and infectious diseases consultation were associated with a reduction in mortality rates. No statistically significant differences were observed in mortality between vancomycin-susceptible and vancomycin-resistant BSIs. CONCLUSIONS: Mortality in EF BSIs was influenced by host- and disease-specific factors, including disease severity. Vancomycin resistance did not appear to have an impact on mortality. Early source control and infectious disease consultation played a critical role in improving survival. Future research should focus on prospective validation of these predictors and the development of tools and scores for early identification of high-risk populations, optimizing clinical management and patient outcomes.
Long Term Metabolic Outcomes Following Pancreatectomy and Autologous Islet Transplantation: Systematic Review and Meta-Analysis Daniel L. Hughes, Caterina Di Bella, Benedetta Quaratino, Pietro Rigo, Giulia Cirillo, Gioia Sgrinzato, Umberto Cillo, Lucrezia Furian, Giovanni Marchegiani Journal of Surgical Oncology, 2026 This systematic review and meta‐analysis assessed long‐term outcomes following total pancreatectomy with islet autotransplantation (TPIAT). Seventeen studies including 1332 patients were analyzed. The pooled insulin independence rate was 34%, with higher rates for non‐chronic pancreatitis indications (68%) versus chronic pancreatitis (33%). TPIAT is effective in preserving endocrine function. Further studies are needed to validate outcomes across extended indications and to standardize reporting, incorporating metabolic markers and patient‐reported quality‐of‐life endpoints over long‐term follow‐up.
Impact of Vancomycin Resistance on 30-Day Mortality in Solid Organ Transplant Recipients with Enterococcus faecium Bloodstream Infections: A Retrospective Cohort Analysis Maria Mazzitelli, Alberto Enrico Maraolo, Umberto Barbieri, Vincenzo Scaglione, Lolita Sasset, Lucrezia Furian, Umberto Cillo, Gino Gerosa, Monica Loy, Emanuele Cozzi, Patrizia Burra, Federico Rea, Annamaria Cattelan Antibiotics, 2026 Background: Enterococcus faecium bloodstream infections (EF-BSI) cause significant morbidity and mortality in solid organ transplant (SOT) recipients, with the role of vancomycin resistance (VR) remaining controversial as an independent driver. Methods: This was a retrospective cohort study including SOT recipients with EF-BSI at our institution from 2019 to 2023. We used Cox proportional hazards regression to identify predictors of 30-day all-cause mortality. A time-dependent covariate was used to model the effects of receiving targeted, effective antibiotic therapy. Results: A total of 79 patients were included (26.6%, with VR). The overall 30-day mortality was 12.7% (10/79). In univariable analysis, septic shock (Hazard Ratio, HR: 17.1, 95% CI: 3.64–80.8, p < 0.001), the need for Continuous Venovenous Hemofiltration (HR: 6.40, 95% CI: 1.85–22.1, p = 0.003), and a Pitt Bacteremia Score ≥ 2 (HR: 5.17, 95%CI: 1.10–24.3, p = 0.038) were associated with increased mortality, while source control was protective (HR: 0.20, 95% CI: 0.05–0.76, p = 0.018). In the final multivariable model, only septic shock remained an independent predictor of 30-day mortality (HR: 11.4, 95% CI: 1.63–79.5, p = 0.014). VR was not significantly associated with mortality, though the confidence interval was wide and included clinically meaningful effects (HR: 2.07, 95% CI: 0.40–10.6, p = 0.4). Conclusions: In SOT recipients with EF-BSI, 30-day mortality is overwhelmingly driven by the host’s physiological response, manifested as septic shock, rather than the VR profile of the pathogen. The early recognition of severe sepsis/septic shock and the aggressive implementation of supportive care and source control measures in this setting are crucial.
The Italian landscape of robotic-assisted kidney transplantation: results from a national survey C. Guidetti, S. Serni, U. Boggi, A. Solinas, F. Tanese, A. Lauterio, A. Volpe, B. Catellani, G. P. Guerrini, T. M. Manzia, D. Lorenzin, A. Puzziello, M. Romano, M. Spada, A. Antonelli, G. Carcano, N. Bossini, M. Iaria, M. Vivarelli, M. Rossi, P. Rigotti, L. Furian, R. I. Troisi, S. Di Sandro, F. Di Benedetto Updates in Surgery, 2026 Robotic-assisted kidney transplantation (RAKT) is an emerging minimally invasive alternative to open surgery that offers potential benefits in selected recipients. Despite increasing international interest, its implementation across transplant centers remains variable. This study aims to describe the current status, challenges, and perspectives on RAKT in Italy through a nationwide survey. A web-based questionnaire was distributed to all active kidney transplant centers in Italy. The survey collected data on institutional experience, surgical techniques, intraoperative technologies, perceived barriers, and future directions. Responses were anonymized and analyzed descriptively. Twenty-one out of 39 centers responded (54%). Nine centers were actively performing RAKT at the time of the survey. The median number of RAKT cases per center was 5 (range 1–85), with Da Vinci Xi being the most used platform. Intraoperative tools such as indocyanine green fluorescence and robotic Doppler were variably adopted to verify graft perfusion. Reported operative times ranged from 143 to 410 min (median 215 min), with low conversion rates. Main barriers to adoption included limited access to the robotic platform and lack of structured training. All centers supported the creation of a national registry and expressed interest in collaborative studies. This survey provides the first national overview of RAKT in Italy, highlighting both technical feasibility and structural challenges. The findings support the need for coordinated training efforts, shared data, and policy-level initiatives to foster equitable access to robotic transplant surgery.
Normothermic Kidney Perfusion: Current Status and Future Perspectives Barbara Franchin, Leonie van Leeuwen, Matthew L. Holzner, Nicholas Chun, Lucrezia Furian, Paolo Cravedi Kidney International Reports, 2025 maintenance of grafts in a physiologically active state, offering a significant advantage over traditional cold storage methods. Whereas NMP is now widely adopted for clinical preservation of livers, hearts, and lungs, its application in kidney transplantation remains relatively limited. In this context, NMP holds promise for expanding the use of marginal donor kidneys by enhancing viability assessment and potentially restoring function in grafts that might otherwise be discarded. In addition, NMP provides a valuable platform for studying molecular markers of injury and recovery in human organs, as well as for delivering targeted therapies aimed at modulating immunologic or transcriptomic profiles. Despite its potential, broader clinical implementation is hindered by variability in perfusion devices, protocols, and perfusate compositions across centers, making cross-study comparisons challenging. This review examines the current landscape of kidney NMP and its emerging role in graft reconditioning.
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data Giorgio Cazzaniga, Giulia Capitoli, Raffaella Barretta, Andrew Smith, Gisella Vischini, Giuliana Papalia, Federico Alberici, Federica Mescia, Albino Eccher, Jan Ulrich Becker, Maarten Naesens, Lucrezia Furian, Bernd Schröppel, Stefania Galimberti, Fabio Pagni, Vincenzo L'Imperio Kidney International Reports, 2025 Introduction: The prompt detection of monoclonal gammopathies of renal significance (MGRS) is clinically relevant for the initiation of chemotherapy. Although clinical and laboratory data can suggest the presence of MGRS, renal biopsy still represents the gold standard, despite not always being performed or eventually postponed because it is not deemed useful or informative. In this retrospective study, machine learning (ML) is used to build a tool to assist the prebiopsy risk stratification of MGRS and reinforce the rationale for the histological examination. Methods: The study included a total of 258 patients with monoclonal gammopathy of undetermined significance, of which 168 MGRS cases (65%) and 90 non-MGRS cases (35%) based on the final renal biopsy result. Results: < 0.001) than non-MGRS cases, with amyloidosis being the most common diagnosis (62%). The ML model achieved an accuracy of 0.79 (95% confidence interval [CI]: 0.67-0.88) and an area under the receiver operating characteristic curve of 0.80 (95% CI: 0.65-0.93) in the validation set. The model is available as a free desktop and Android mobile app (MGRS Interactive Resource for AI-Guided Evaluation, MIRAGE). Conclusion: The ML-based MGRS risk stratification tool can help in the selection of patients with higher probability to have MGRS on renal biopsy, aiming to direct those patients to a complete histological characterization of the disease.
Imlifidase: A new interferent on serum protein electrophoresis looking as a rare plasma cell dyscrasia Veronica Davanzo, Sara Altinier, Irene Olimpo, Erica Nuzzolese, Lucrezia Furian, Daniela Basso Clinical Chemistry and Laboratory Medicine, 2025 Article Imlifidase: a new interferent on serum protein electrophoresis looking as a rare plasma cell dyscrasia was published on June 1, 2025 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 63, issue 7).
Fungal Infections in Kidney Transplant Recipients: A Comprehensive Narrative Review Maria Mazzitelli, Federico Nalesso, Alberto Enrico Maraolo, Vincenzo Scaglione, Lucrezia Furian, Annamaria Cattelan Microorganisms, 2025 Background: Despite kidney transplantation being a life-saving procedure, patients experience a high risk of developing fungal infections (FIs), with an increased risk of both morbidity and mortality, especially during the first year after transplant. Methods: We herein conducted a narrative review of the most common FIs in kidney transplant recipients (KTRs), with a focus on prevalence, risk factors, mortality, and prevention strategies. Results: The most common fungal pathogens in KTRs include Candida species (up to 70% of the overall FIs), Aspergillus species, Pneumocystis jiroveci, and Cryptococcus species. Fungal colonization, diabetes mellitus, chronic liver disease, malnutrition, and pre-existing lung conditions should all be acknowledged as possible predisposing risk factors. The mortality rate can vary from 25 to 50% and according to different settings and the types of FIs. Preventive strategies are critical for reducing the incidence of FIs in this population. These include antifungal prophylaxis, environmental precautions, and infection control measures. The use of novel tools (such as PCR-based molecular assays and NGS) for rapid and accurate diagnosis may play an important role. Conclusions: Early recognition, the appropriate use of antifungal therapy, and preventive strategies are essential for improving graft loss and fatal outcomes in this vulnerable population. Future research is needed to optimize diagnostic tools, identify novel antifungal agents, and develop better prophylactic strategies for high-risk transplant recipients.
Living Kidney Donation Practices in Europe: A Survey of DESCaRTES and EKITA Transplantation Working Groups Marco van Londen, François Gaillard, Gianluigi Zaza, Gabriel C. Oniscu, Ilaria Gandolfini, Lucrezia Furian, Jelena Stojanovic, David Cucchiari, Luuk B. Hilbrands, Geir Mjøen, Christophe Mariat Transplant International, 2025 Thorough evaluation of potential kidney donors ensures safety and graft quality, but European data on donor practices are lacking. An online survey was conducted to assess European practices regarding kidney function, risk assessment and follow-up. 56% of respondents (125 practitioners, 16 countries, ∼3700 donations annually) use eGFRCKD-EPI, 34% use creatinine clearance and 70% use measured GFR. Sixty-three percent have no upper age limits, 91% exclude candidates with hypertension with end-organ damage, and 78% candidates on ≥2 antihypertensives. BMI cut-offs of 30 (39%) and 35 kg/m2 (42%) are common. Candidates are excluded for an HbA1c ≥ 53 mmol/mol (46%), glucose ≥7 (57%) or ≥11.1 mmol/L after glucose-tolerance test (59%). ApoL1-testing is not routine in 73%, and 38% perform a kidney biopsy if albuminuria/hematuria is present. Spot and 24-hour urine albumin is assessed in 38%. Hematuria is accepted when urological evaluation (15%), kidney biopsy (16%), or both (57%) are normal. Low-risk stones often do not preclude donation. Written informed consent is obtained by 95% of centers, with 65% asking consent for data. Lifetime follow-up is offered by 83%. This first study on evaluation and follow-up practices of donors in Europe shows variation between centers, suggesting a need for harmonization of donor practices.
Evaluating Risk in Kidney Living Donors Fernanda Ortiz, Lorna Marson, Rachel Thomas, Andreas Kousios, Elvana Rista, Carmen Lefaucheur, Sanem Cimen, David Cucchiari, Gianluigi Zaza, Lucrezia Furian, Baris Akin Transplant International, 2025
Cancer mortality after kidney transplantation: A multicenter cohort study in Italy Martina Taborelli, Diego Serraino, Claudia Cimaglia, Lucrezia Furian, Luigi Biancone, Ghil Busnach, Nicola Bossini, Franco Citterio, Massimiliano Veroux, Maurizio Iaria, Davide Argiolas, Paola Todeschini, Tommaso Maria Manzia, Francesco Pisani, Vincenzo Cantaluppi, Simona Simone, Margherita Mangino, Mariarosaria Campise, Andrea Ambrosini, Flavia Caputo, Pierluca Piselli, and International Journal of Cancer, 2024
Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus Lucrezia Furian, Uwe Heemann, Mats Bengtsson, Oriol Bestard, Isabelle Binet, Georg A. Böhmig, John Boletis, David Briggs, Frans H. J. Claas, Lionel Couzi, Emanuele Cozzi, Marta Crespo, Aiko P. J. De Vries, Fritz Diekmann, Magdalena Durlik, Denis Glotz, Ilkka Helantera, Annette Jackson, Stanley C. Jordan, Dirk Kuypers, Carmen Lefaucheur, Christophe Legendre, Tomas Lorant, Umberto Maggiore, Nizam Mamode, Smaragdi Marinaki, Annick Massart, Thomas Müller, Rainer Oberbauer, Lutz Renders, Dave Roelen, Jean-Luc Taupin, Ondřej Viklický, Angeliki Vittoraki, Annelies E. de Weerd, Maarten Naesens Transplant International, 2024
Variation in Post-Transplant Cancer Incidence among Italian Kidney Transplant Recipients over a 25-Year Period Pierluca Piselli, Diego Serraino, Claudia Cimaglia, Lucrezia Furian, Luigi Biancone, Ghil Busnach, Nicola Bossini, Paola Todeschini, Maurizio Iaria, Franco Citterio, Mariarosaria Campise, Massimiliano Veroux, Giuseppe Tisone, Vincenzo Cantaluppi, Margherita Mangino, Simona Simone, Davide Argiolas, Andrea Ambrosini, Francesco Pisani, Flavia Caputo, Martina Taborelli Cancers, 2023
ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process Umberto Cillo, Annemarie Weissenbacher, Liset Pengel, Ina Jochmans, Daniele Roppolo, Cristiano Amarelli, Luca S. Belli, Marina Berenguer, Aiko De Vries, Joana Ferrer, John Friedewald, Lucrezia Furian, Sharlene Greenwood, Diethard Monbaliu, Silvio Nadalin, Arne Neyrinck, Mario Strazzabosco, Christian Toso, Gianluigi Zaza, Raj Thuraisingham, Thierry Berney, Luciano Potena, Nuria Montserrat, Nazia Selzner Transplant International, 2022
Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation Luuk Hilbrands, Klemens Budde, Maria Irene Bellini, Fritz Diekmann, Lucrezia Furian, Josep Grinyó, Uwe Heemann, Dennis A. Hesselink, Alexandre Loupy, Rainer Oberbauer, Liset Pengel, Marlies Reinders, Stefan Schneeberger, Maarten Naesens Transplant International, 2022
Alloimmune Risk Stratification for Kidney Transplant Rejection Oriol Bestard, Olivier Thaunat, Maria Irene Bellini, Georg A. Böhmig, Klemens Budde, Frans Claas, Lionel Couzi, Lucrezia Furian, Uwe Heemann, Nizam Mamode, Rainer Oberbauer, Liset Pengel, Stefan Schneeberger, Maarten Naesens Transplant International, 2022
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort Maddalena Giannella, Elda Righi, Renato Pascale, Matteo Rinaldi, Natascia Caroccia, Chiara Gamberini, Zaira R. Palacios-Baena, Giulia Caponcello, Maria Cristina Morelli, Mariarosa Tamè, Marco Busutti, Giorgia Comai, Luciano Potena, Elena Salvaterra, Giuseppe Feltrin, Umberto Cillo, Gino Gerosa, Mara Cananzi, Salvatore Piano, Elisa Benetti, Patrizia Burra, Monica Loy, Lucrezia Furian, Gianluigi Zaza, Francesco Onorati, Amedeo Carraro, Fiorella Gastaldon, Maurizio Nordio, Samir Kumar-Singh, Mahsa Abedini, Paolo Boffetta, Jesús Rodríguez-Baño, Tiziana Lazzarotto, Pierluigi Viale, Evelina Tacconelli, and Microorganisms, 2022
The impact of cancer on the risk of death with a functioning graft of Italian kidney transplant recipients Martina Taborelli, Diego Serraino, Claudia Cimaglia, Lucrezia Furian, Luigi Biancone, Ghil Busnach, Paola Todeschini, Nicola Bossini, Maurizio Iaria, Maria R. Campise, Massimiliano Veroux, Franco Citterio, Andrea Ambrosini, Vincenzo Cantaluppi, Margherita Mangino, Francesco Pisani, Giuseppe Tisone, Marco Fiorentino, Davide Argiolas, Flavia Caputo, Pierluca Piselli American Journal of Transplantation, 2022
First World Consensus Conference on pancreas transplantation: Part II – recommendations Ugo Boggi, Fabio Vistoli, Axel Andres, Helmut P. Arbogast, Lionel Badet, Walter Baronti, Stephen T. Bartlett, Enrico Benedetti, Julien Branchereau, George W. Burke, Fanny Buron, Rossana Caldara, Massimo Cardillo, Daniel Casanova, Federica Cipriani, Matthew Cooper, Adamasco Cupisti, Josè Davide, Cinthia Drachenberg, Eelco J.P. de Koning, Giuseppe Maria Ettorre, Laureano Fernandez Cruz, Jonathan A. Fridell, Peter J. Friend, Lucrezia Furian, Osama A. Gaber, Angelika C. Gruessner, Rainer W.G. Gruessner, Jenny E. Gunton, Duck-Jong Han, Sara Iacopi, Emanuele Federico Kauffmann, Dixon Kaufman, Takashi Kenmochi, Hussein A. Khambalia, Quirino Lai, Robert M. Langer, Paola Maffi, Lorella Marselli, Francesco Menichetti, Mario Miccoli, Shruti Mittal, Emmanuel Morelon, Niccolò Napoli, Flavia Neri, Jose Oberholzer, Jon S. Odorico, Robert Öllinger, Gabriel Oniscu, Giuseppe Orlando, Monica Ortenzi, Marcelo Perosa, Vittorio Grazio Perrone, Henry Pleass, Robert R. Redfield, Claudio Ricci, Paolo Rigotti, R. Paul Robertson, Lainie F. Ross, Massimo Rossi, Frantisek Saudek, Joseph R. Scalea, Peter Schenker, Antonio Secchi, Carlo Socci, Donzilia Sousa Silva, Jean Paul Squifflet, Peter G. Stock, Robert J. Stratta, Chiara Terrenzio, Pablo Uva, Christopher J.E. Watson, Steven A. White, Piero Marchetti, Raja Kandaswamy, Thierry Berney American Journal of Transplantation, 2021
A clinical evaluation of VO2 kinetics in kidney transplant recipients Alessandro Patti, Daniel Neunhaeuserer, Sara Ortolan, Fausto Roman, Andrea Gasperetti, Francesca Battista, Caterina Di Bella, Stefano Gobbo, Marco Bergamin, Lucrezia Furian, Andrea Ermolao European Journal of Applied Physiology, 2021
Advantages of using a web-based digital platform for kidney preimplantation biopsies Flavia Neri, Albino Eccher, Paolo Rigotti, Ilaria Girolami, Gianluigi Zaza, Giovanni Gambaro, MariaGaia Mastrosimini, Giulia Bencini, Caterina Di Bella, Claudia Mescoli, Luigino Boschiero, Stefano Marletta, Paolo Angelo Dei Tos, Lucrezia Furian Journal of Pathology Informatics, 2021
COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium Paolo Cravedi, Suraj S. Mothi, Yorg Azzi, Meredith Haverly, Samira S. Farouk, María J. Pérez-Sáez, Maria D. Redondo-Pachón, Barbara Murphy, Sander Florman, Laura G. Cyrino, Monica Grafals, Sandheep Venkataraman, Xingxing S. Cheng, Aileen X. Wang, Gianluigi Zaza, Andrea Ranghino, Lucrezia Furian, Joaquin Manrique, Umberto Maggiore, Ilaria Gandolfini, Nikhil Agrawal, Het Patel, Enver Akalin, Leonardo V. Riella American Journal of Transplantation, 2020
COVID-19 and kidney transplantation: an Italian Survey and Consensus Fabio Vistoli, Lucrezia Furian, Umberto Maggiore, Rossana Caldara, Vincenzo Cantaluppi, Mariano Ferraresso, Gianluigi Zaza, Massimo Cardillo, Giandomenico Biancofiore, Francesco Menichetti, Alessandro Russo, Emanuela Turillazzi, Marco Di Paolo, Giuseppe Grandaliano, Ugo Boggi, on behalf of the Italian National Kidney Transplantation Network, Giuliano Brunori, Flavia Petrini, Franco Valenza, Bruna Lavezzo, Decenzio Bonucchi, Enzo Capocasale, Paolo Grossi, Claudio Ponticelli, Silvio Sandrini, Francesco Paolo Schena, Giuseppe Segoloni, Luigi Biancone, Luigino Boschiero, Paolo Rigotti, Giorgia Comai, Nicola Bossini, Enrico Minetti, Giuseppe Iaria, Andrea Ambrosini, Pier Giorgio Messa, Giuliano Boscutti, Mario Carmellini, Flavia Caputo, Andrea Ranghino, Paride De Rosa, Stefano Federico, Massimiliano Veroux, Calogero Cirami, Maurizio Nordio, Franco Citterio, Gian Benedetto Piredda, Renzo Pretagostini, Paolo De Paolis, Teresa Rampino, Francesco Pisani, Gianni Cappelli, Antonio Secchi, Paola Salis, Fiorella Gastaldon, Francesca Mallamaci, Luca Dello Strologo, Chiara Taglioni, Papalia Teresa, Licia Peruzzi, Loreto Gesualdo, Eliana Gotti, Paolo Feltracco, Ernesto Paoletti, the Joint Committee of the Italian Society of Organ Transplantation, the Italian Society of Nephrology Journal of Nephrology, 2020
Impact of SARS-CoV-2 on pancreas transplant activity: Survey of international surgeons World Pancreas Transplant Covid-19 Collaborative Group, S K Kamarajah, H Arbogast, T Berney, U Boggi, J Branchereau, C Socci, D Casanova, M Cooper, M Drage, D Elker, J Ferrer, L Furian, R Gruessner, S Harper, A Kwiatkowski, T Kenmochi, D Manas, E Morelon, J Odorico, R Oellinger, G Oniscu, M Perosa, F Saudek, J Scalea, P Schenker, R Stratta, F Vistulo, P Uva, S A White British Journal of Surgery, 2020
Interleukin-27 is a potential marker for the onset of post-transplant malignancies Paola Pontrelli, Federica Rascio, Gianluigi Zaza, Matteo Accetturo, Simona Simone, Barbara Infante, Lucrezia Furian, Giuseppe Castellano, Pasquale Ditonno, Michele Battaglia, Luigi Cormio, Giuseppe Carrieri, Antonio Lupo, Paolo Rigotti, Loreto Gesualdo, Giovanni Stallone, Giuseppe Grandaliano Nephrology Dialysis Transplantation, 2019
Effects of immune suppression for transplantation on inflammatory colorectal cancer progression Imerio Angriman, Lucrezia Furian, Melania Scarpa, Matteo Fassan, Susan Morgan, Andrea Porzionato, Andromachi Kotsafti, Luca Saadeh, Cristina Silvestre, Raffaele De Caro, Amedeo Carraro, Umberto Tedeschi, Romeo Bardini, Paolo Rigotti, Massimo Rugge, Carlo Castoro, Ignazio Castagliuolo, Marco Scarpa Oncogenesis, 2018
Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy Matteo Ravaioli, Enzo Capocasale, Lucrezia Furian, Vanessa De Pace, Maurizio Iaria, Gionata Spagnoletti, Maria Paola Salerno, Alessandro Giacomoni, Luciano De Carlis, Caterina Di Bella, Nguefouet Momo Rostand, Luigino Boschiero, Giovanni Pasquale, Andrea Bosio, Andrea Collini, Mario Carmellini, Andrea Airoldi, Gianmarco Bondonno, Pasquale Ditonno, Stefano Vittorio Impedovo, Claudio Beretta, Antenore Giussani, Carlo Socci, Danilo Carlo Parolini, Massimo Abelli, Elena Ticozzelli, Umberto Baccarani, Gian Luigi Adani, Flavia Caputo, Barbara Buscemi, Mauro Frongia, Andrea Solinas, Salvatore Gruttadauria, Marco Spada, Antonio Daniele Pinna, Jacopo Romagnoli Nephrology Dialysis Transplantation, 2017
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection Claudia Curci, Fabio Sallustio, Grazia Serino, Giuseppe De Palma, Mirko Trpevski, Marco Fiorentino, Michele Rossini, Marco Quaglia, Marialuisa Valente, Lucrezia Furian, Alessia Toscano, Gianna Mazzucco, Antonella Barreca, Stefania Bussolino, Loreto Gesualdo, Piero Stratta, Paolo Rigotti, Franco Citterio, Luigi Biancone, Francesco P. Schena Nephrology Dialysis Transplantation, 2016
Laparoscopic and robot-assisted nephrectomy Alessandro Giacomoni, Lucrezia Furian, Giacomo Concone, Paolo Rigotti Multiorgan Procurement for Transplantation A Guide to Surgical Technique and Management, 2016
Hepatitis C virus infection in end-stage renal disease and kidney transplantation Patrizia Burra, Kryssia I. Rodríguez-Castro, Francesco Marchini, Luciana Bonfante, Lucrezia Furian, Alberto Ferrarese, Alberto Zanetto, Giacomo Germani, Francesco Paolo Russo, Marco Senzolo Transplant International Official Journal of the European Society for Organ Transplantation, 2014
Early activation of fibrogenesis in transplanted kidneys: A study on serial renal biopsies Dorella Del Prete, Monica Ceol, Franca Anglani, Daniela Vianello, Emilia Tiralongo, Marialuisa Valente, Romina Graziotto, Luciana Bonfante, Giuseppe Scaparrotta, Lucrezia Furian, Paolo Rigotti, Giovanni Gambaro, Angela D'Angelo Experimental and Molecular Pathology, 2009
Outcome of renal transplantation from very old donors Paolo Rigotti, Burcin Ekser, Lucrezia Furian, Nicola Baldan, Maria Luisa Valente, Luigino Boschiero, Nicola Motterlini, Annalisa Perna, Giuseppe Remuzzi, Piero Ruggenenti New England Journal of Medicine, 2009
[Living donor kidney transplant: the surgical procedure]. Giornale Italiano Di Nefrologia Organo Ufficiale Della Societa Italiana Di Nefrologia, 2009
Combined Liver and Kidney Transplantation: Analysis of Padova Experience G. Zanus, A. Carraro, A. Vitale, P. Boccagni, A. Brolese, D. Neri, N. Srsen, E. Gringeri, M. Valmasoni, F. D’Amico, F.A. Ciarleglio, P. Violi, P. Bonsignore, A. Pauletto, D. Bassi, F. D’Amico, P. Burra, A. Masier, P. Rigotti, L. Furian, M. Polacco, D.F. D’Amico, U. Cillo Transplantation Proceedings, 2007
